SYNRG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.528800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.546200E-01
Normal-vs-Stage2
3.461200E-01
Normal-vs-Stage3
2.660600E-01
Normal-vs-Stage4
3.653600E-01
Stage1-vs-Stage2
2.579400E-01
Stage1-vs-Stage3
1.218750E-01
Stage1-vs-Stage4
8.812000E-01
Stage2-vs-Stage3
2.892400E-01
Stage2-vs-Stage4
2.562000E-01
Stage3-vs-Stage4
5.712100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.495800E-01
Normal-vs-AfricanAmerican
3.032000E-01
Normal-vs-Asian
2.975000E-01
Caucasian-vs-AfricanAmerican
1.289850E-01
Caucasian-vs-Asian
2.877600E-01
AfricanAmerican-vs-Asian
4.296000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.362200E-01
Normal-vs-Female
3.759000E-01
Male-vs-Female
1.685960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.550600E-01
Normal-vs-Age(41-60Yrs)
4.195600E-01
Normal-vs-Age(61-80Yrs)
3.283200E-01
Normal-vs-Age(81-100Yrs)
2.789400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.202400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.867800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.142600E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.937900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.935800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.024200E-01
Normal-vs-Daily Drinker
2.905000E-01
Normal-vs-Weekly Drinker
2.834000E-01
Normal-vs-Occasional Drinker
4.112600E-01
Normal-vs-Social Drinker
1.126830E-01
Non Drinker-vs-Daily Drinker
7.386600E-01
Non Drinker-vs-Weekly Drinker
6.270000E-01
Non Drinker-vs-Occasional Drinker
4.651600E-02
Non Drinker-vs-Social Drinker
8.482100E-02
Daily Drinker-vs-Weekly Drinker
8.345400E-01
Daily Drinker-vs-Occasional Drinker
2.641600E-02
Daily Drinker-vs-Social Drinker
9.505900E-02
Weekly Drinker-vs-Occasional Drinker
3.749500E-02
Weekly Drinker-vs-Social Drinker
8.339600E-02
Occasional Drinker-vs-Social Drinker
9.621000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.006040E-01
Normal-vs-Grade 2
4.226500E-02
Normal-vs-Grade 3
1.809780E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.694200E-01
Grade 1-vs-Grade 3
3.583800E-01
Grade 1-vs-Grade 4
1.006040E-01
Grade 2-vs-Grade 3
7.844800E-01
Grade 2-vs-Grade 4
4.226500E-02
Grade 3-vs-Grade 4
1.809780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.271600E-01
Normal-vs-NonDiabetic
3.374600E-01
Diabetic-vs-NonDiabetic
7.135600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.046400E-01
Normal-vs-NoPancreatitis
3.382200E-01
Pancreatitis-vs-NoPancreatitis
4.562800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.527800E-01
Normal-vs-N1
3.497800E-01
N0-vs-N1
9.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.232400E-01
Normal-vs-TP53-NonMutant
4.272600E-01
TP53-Mutant-vs-TP53-NonMutant
1.769510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
